Free Trial
CVE:HIV

HIVE Blockchain Technologies (HIV) Stock Price, News & Analysis

HIVE Blockchain Technologies logo

About HIVE Blockchain Technologies Stock (CVE:HIV)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive HIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HIVE Blockchain Technologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HIV Stock News Headlines

What is Northland Capmk's Estimate for CVE:HIV Q2 Earnings?
Research Analysts Offer Predictions for CVE:HIV Q4 Earnings
Altucher: It Looks Like My Trump prediction is coming true
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.tc pixel
Hive scales hashrate to 21 EH/s with Paraguay expansion
Why HIVE Stock Zoomed 20% Monday
See More Headlines

HIV Stock Analysis - Frequently Asked Questions

HIVE Blockchain Technologies Ltd. (CVE:HIV) announced its earnings results on Tuesday, November, 12th. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.04.

Shares of HIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that HIVE Blockchain Technologies investors own include ProShares Bitcoin ETF (BITO), Meta Platforms (META), Broadcom (AVGO), Marathon Digital (MARA), NVIDIA (NVDA), Riot Platforms (RIOT) and Shopify (SHOP).

Company Calendar

Last Earnings
11/12/2024
Today
10/16/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Services – Management, Public Relations, Consulting
Sub-Industry
Business Services
Current Symbol
CVE:HIV
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:HIV) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners